Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co
27/09/2023 07:37
Sept 27 (Reuters) - Arix Bioscience PLC ARIX.L :
* ARIX BIOSCIENCE PLC INTERIM RESULTS FOR THE SIX MONTHS
ENDED 30
JUNE 2023
* ARIX BIOSCIENCE PLC - BOARD BEEN EXPLORING RANGE OF
STRATEGIC
OPTIONS FOR CO
Source text for Eikon: ID:nEQ9fFtJWa
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co